(NASDAQ: ZLAB) Zai Lab's forecast annual revenue growth rate of 42.8% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 237.23%, and while it is forecast to beat the US market's average forecast revenue growth rate of 11.8%.
Zai Lab's revenue in 2025 is $418,326,000.On average, 3 Wall Street analysts forecast ZLAB's revenue for 2025 to be $605,438,938,020, with the lowest ZLAB revenue forecast at $594,027,432,613, and the highest ZLAB revenue forecast at $614,615,871,076. On average, 3 Wall Street analysts forecast ZLAB's revenue for 2026 to be $910,121,793,417, with the lowest ZLAB revenue forecast at $879,727,270,460, and the highest ZLAB revenue forecast at $943,249,870,902.
In 2027, ZLAB is forecast to generate $1,275,680,474,237 in revenue, with the lowest revenue forecast at $1,275,680,474,237 and the highest revenue forecast at $1,275,680,474,237.